Sort by
Refine Your Search
-
conformational analyses to establish molecular solution conformations to drive lead compound optimizations. Contribute to the development of new technology in ATCM such as microscale high-throughput NMR, high
-
chemistry team in a lab-based role in Bothell Washington to support novel ADC technology development. The successful candidate will participate in research projects involving the design and synthesis of novel
-
, chemists, and protein engineers to innovate and develop first-in-class oncology therapies. The successful candidate should have a record of being a strong scientist, team player, strategic thinker, and an
-
experienced biomedical engineer with automation experience to support several mRNA vaccine programs. In this position, you will actively support the technology transfer and integration of a new laboratory with
-
organize/prioritize work efficiently and effectively Experience designing and building building reusable code infrastructure and work with engineering teams Strong written and verbal communication skills
-
Plan, execute and analyze in vivo pharmacology studies Characterize new in vivo mouse models, including syngeneic tumor and genetically engineered mouse (GEM) models, to study biologic mechanisms and
-
combines research and technology units that have deep disease area expertise and cutting-edge science and platforms to discover and develop innovative therapeutic programs in small molecules and
-
of laboratory operations including mass spec technology evaluation, proteomic software evaluation, development of quantitative sample preparation methods and peptide separation methods, data analysis and
-
science (e.g. biology, cell biology, immunology, virology, microbiology) or bioengineering/biomedical engineering with at least 3 years of experience or MA/MS degree with at least 1-2 years of laboratory
-
identification and analysis. Supervise and guide a small team of scientists Develop and characterize new in vivo mouse models, including cell-line derived xenografts, syngeneic tumor and genetically engineered